Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial.

Nicoletta ColomboElena BiagioliKenichi HaranoFrancesca GalliEmma HudsonYoland AntillChel Hun ChoiManuela RabaglioFrederic MarméChristian MarthGabriella ParmaLorena Fariñas-MadridShin NishioKaren AllanYeh Chen LeeElisa PiovanoBeatriz PardoSatoshi NakagawaJohn McQueenClaudio ZamagniLuis MansoKazuhiro TakeharaGiulia TascaAnnamaria FerreroGermana TognonAndrea Alberto LissoniMariacristina PetrellaMaria Elena LaudaniEliana RulliSara UggeriM Pilar Barretina Ginestanull null

Published in: The Lancet. Oncology (2024)

F Hoffmann-La Roche.

Keyphrases

endometrial cancer
placebo controlled
double blind
clinical trial
phase iii
phase ii
locally advanced
study protocol
phase ii study
squamous cell carcinoma
randomized controlled trial
radiation therapy
open label